Inventor · disambiguated record
Otis Clinton Attucks
Also filed as: ATTUCKS OTIS CLINTON
13 granted patents·4 pending applications·56 citations·filing 2011–2023
91Inventor score
Top patents by PatentIndex Score
17 records- 0195US10287284B2Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereofVTV THERAPEUTICS LLC·Filed 2018·Granted May 14, 2019·14 cites·22 claims
- 0293US11130753B2Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereofVTV THERAPEUTICS LLC·Filed 2020·Granted Sep 28, 2021·2 cites·29 claims
- 0392US8759535B2Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereofMJALLI ADNAN M M·Filed 2011·Granted Jun 24, 2014·15 cites·49 claims
- 0490US11649230B2Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereofVTV THERAPEUTICS LLC·Filed 2021·Granted May 16, 2023·1 cites·29 claims
- 0590US10889580B2Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereofVTV THERAPEUTICS LLC·Filed 2020·Granted Jan 12, 2021·2 cites·20 claims
- 0688US9447468B2Compounds that modulate oxidative stressVTV THERAPEUTICS LLC·Filed 2013·Granted Sep 20, 2016·5 cites·12 claims
- 0787US9707239B2Compounds that modulate oxidative stressVTV THERAPEUTICS LLC·Filed 2016·Granted Jul 18, 2017·3 cites·7 claims
- 0885US10463652B2Bach1 inhibitors in combination with Nrf2 activators and pharmaceutical compositions thereofVTV THERAPEUTICS LLC·Filed 2018·Granted Nov 5, 2019·4 cites·7 claims
- 0985US10172840B2Bach1 inhibitors in combination with Nrf2 activators and pharmaceutical compositions thereofVTV THERAPEUTICS LLC·Filed 2017·Granted Jan 8, 2019·4 cites·6 claims
- 1084US10898475B2Bach1 inhibitors in combination with Nrf2 activators and pharmaceutical compositions thereofVTV THERAPEUTICS LLC·Filed 2019·Granted Jan 26, 2021·2 cites·18 claims
- 1183US10570126B2Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereofVTV THERAPEUTICS LLC·Filed 2019·Granted Feb 25, 2020·2 cites·21 claims
- 1278US10030011B2Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereofVTV THERAPEUTICS LLC·Filed 2014·Granted Jul 24, 2018·2 cites·33 claims
- 1369US2021069159A1Bach1 Inhibitors in Combination with Nrf2 Activators and Pharmaceutical Compositions ThereofVTV THERAPEUTICS LLC·Filed 2020·Application pending·0 cites
- 1464US2021283111A1Methods of Inhibiting Osteoclastogenesis and Osteoclast ActivityVTV THERAPEUTICS LLC·Filed 2021·Application pending·0 cites
- 1563US12091407B2Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereofVTV THERAPEUTICS LLC·Filed 2023·Granted Sep 17, 2024·0 cites·28 claims
- 1662US2021338644A1Substituted Fused Imidazole Derivatives and Methods of Treating Sickle Cell Disease and Related ComplicationsVTV THERAPEUTICS LLC·Filed 2021·Application pending·0 cites
- 1753US2023093476A1Substituted fused imidazole derivatives and methods of treating refractive ocular disordersVTV THERAPEUTICS LLC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Otis Clinton Attucks files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →